Cargando…

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1–Infected Adults in the United States

BACKGROUND: Cerebrospinal fluid (CSF) viral escape occurs in 4%–20% of human immunodeficiency virus (HIV)–infected adults, yet the impact of antiretroviral therapy (ART) on CSF escape is unclear. METHODS: A prospective study of 1063 participants with baseline plasma viral load (VL) ≤400 copies/mL be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukerji, Shibani S, Misra, Vikas, Lorenz, David R, Uno, Hajime, Morgello, Susan, Franklin, Donald, Ellis, Ronald J, Letendre, Scott, Gabuzda, Dana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160603/ https://www.ncbi.nlm.nih.gov/pubmed/29617912 http://dx.doi.org/10.1093/cid/ciy267

Ejemplares similares

Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy
por: Guha, Debjani, et al.
Publicado: (2019)

Low Neuroactive Steroids Identifies a Biological Subtype of Depression in Adults with Human Immunodeficiency Virus on Suppressive Antiretroviral Therapy
por: Mukerji, Shibani S, et al.
Publicado: (2020)

CSF Inflammation Markers Associated with Asymptomatic Viral Escape in Cerebrospinal Fluid of HIV-Positive Individuals on Antiretroviral Therapy
por: Guha, Debjani, et al.
Publicado: (2023)

Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults
por: Mukerji, Shibani S., et al.
Publicado: (2017)

Lipid Profiles and APOE4 Allele Impact Midlife Cognitive Decline in HIV-Infected Men on Antiretroviral Therapy
por: Mukerji, Shibani S., et al.
Publicado: (2016)

Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy
por: Guha, Debjani, et al.
Publicado: (2023)

A Plasma Biomarker Signature of Immune Activation in HIV Patients on Antiretroviral Therapy
por: Kamat, Anupa, et al.
Publicado: (2012)

Exosome markers associated with immune activation and oxidative stress in HIV patients on antiretroviral therapy
por: Chettimada, Sukrutha, et al.
Publicado: (2018)

Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment
por: Guha, Debjani, et al.
Publicado: (2019)

Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment
por: Cassol, Edana, et al.
Publicado: (2014)

Transcriptomic analysis of monocytes from HIV-positive men on antiretroviral therapy reveals effects of tobacco smoking on interferon and stress response systems associated with depressive symptoms
por: Lorenz, David R., et al.
Publicado: (2019)

Marijuana Use Impacts Midlife Cardiovascular Events in HIV-Infected Men
por: Lorenz, David R., et al.
Publicado: (2017)

Duration of antiretroviral regimens in treatment-experienced patients in clinical practice
por: Vilaplana, Vicente Escudero, et al.
Publicado: (2010)

Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy
por: Gabuzda, Dana, et al.
Publicado: (2023)

Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection
por: Aldersley, Jordan, et al.
Publicado: (2019)

Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection
por: Cassol, Edana, et al.
Publicado: (2013)

557. Evaluation of Clinical Response of a Two Tablet Once Daily Antiretroviral Regimen in Antiretroviral Experienced HIV-Infected Patients
por: Maki, Gina, et al.
Publicado: (2018)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Symptomatic cerebrospinal fluid HIV-1 escape in two patients on second-line antiretroviral therapy in Uganda
por: Ssebambulidde, Kenneth, et al.
Publicado: (2019)

Experiencing antiretroviral adherence: helping healthcare staff better understand adherence to paediatric antiretrovirals
por: Phelps, Benjamin R, et al.
Publicado: (2010)

Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients
por: Patel, Dishank, et al.
Publicado: (2013)

A study of antiretroviral resistance patterns in treatment experienced and naive human immunodeficiency virus infected-patients
por: Harjani, Raj, et al.
Publicado: (2016)

Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults
por: Lorenz, David R., et al.
Publicado: (2021)

978. Changes in BMI Associated with Antiretroviral Regimens in Treatment-Experienced, Virologically Suppressed Individuals Living with HIV
por: Mounzer, Karam, et al.
Publicado: (2019)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Comparison of Two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV−) Infected Pregnant Women
por: Tate, Danielle, et al.
Publicado: (2017)

Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors
por: Cassol, Edana, et al.
Publicado: (2013)

Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low‐ and middle‐income countries: a multicohort study
por: Zürcher, Kathrin, et al.
Publicado: (2019)

The Successful Application of a National Peer Advisory Committee for Physicians Who Provide Salvage Regimens to Heavily Antiretroviral-Experienced Patients in Mexican Human Immunodeficiency Virus Clinics
por: Calva, Juan J., et al.
Publicado: (2014)

Projected Benefits of Long-Acting Antiretroviral Therapy in Nonsuppressed People With Human Immunodeficiency Virus Experiencing Adherence Barriers
por: Chen, Wanyi, et al.
Publicado: (2023)

Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
por: Sun, Weiwei, et al.
Publicado: (2023)

Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
por: Sun, Weiwei, et al.
Publicado: (2023)

Antiretroviral regimen complexity as a predictor of adherence
por: Boyle, C, et al.
Publicado: (2010)

Designing a Predictive Model for Antiretroviral Regimen at the Antiretroviral Therapy Center in Chiro Hospital, Ethiopia
por: Nemomsa, Gadissa, et al.
Publicado: (2021)

Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens
por: Busca, C, et al.
Publicado: (2022)

Comparison of Cryptococcal Antigenemia between Antiretroviral Naïve and Antiretroviral Experienced HIV Positive Patients at Two Hospitals in Ethiopia
por: Beyene, Tafese, et al.
Publicado: (2013)

Advances and challenges in antiretroviral therapy for acquired immunodeficiency syndrome
por: Bai, Ruo-Jing, et al.
Publicado: (2020)

Combination Antiretroviral Therapy and Immunophenotype of Feline Immunodeficiency Virus
por: Kim, Jeffrey, et al.
Publicado: (2023)

Effectiveness of antiretroviral therapy in the single-tablet regimen era
por: Costa, Juliana de Oliveira, et al.
Publicado: (2018)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g2rbmq6d7fnma30e2m219dasod